Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

ROSKILDE OSTEOPATI ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 0.6% 0.6%   Bankruptcy risk   3.1% 3.9% 6.2% 10.1% 9.0% 7.8% 21.1% 21.1%   Credit score (0-100)   58 51 38 23 27 30 5 5   Credit rating   BBB BBB BBB BB BB BB B B   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   964 1,107 1,230 1,392 1,376 1,384 0.0 0.0   EBITDA   265 383 506 485 267 260 0.0 0.0   EBIT   224 344 477 435 267 260 0.0 0.0   Pre-tax profit (PTP)   257.9 391.0 534.1 441.8 283.3 264.4 0.0 0.0   Net earnings   200.2 313.0 413.6 346.2 220.2 205.2 0.0 0.0   Pre-tax profit without non-rec. items   258 391 534 442 283 264 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   87.9 52.7 49.9 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   438 238 238 238 238 443 0.9 0.9   Interest-bearing liabilities   4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   521 670 860 878 624 636 0.9 0.9   Net Debt   -329 -295 -334 -121 -201 -137 -0.9 -0.9     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   964 1,107 1,230 1,392 1,376 1,384 0.0 0.0   Gross profit growth   8.8% 14.8% 11.2% 13.1% -1.2% 0.6% -100.0% 0.0%   Employees   2 1 2 2 2 2 0 0   Employee growth %   0.0% -50.0% 100.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   521 670 860 878 624 636 1 1   Balance sheet change%   -56.5% 28.7% 28.3% 2.0% -28.9% 1.9% -99.9% 0.0%   Added value   265.1 382.8 506.1 485.3 316.8 260.3 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -48 -78 -35 -100 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   23.2% 31.1% 38.8% 31.3% 19.4% 18.8% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   30.9% 69.5% 70.2% 54.0% 38.3% 42.7% 0.0% 0.0%   ROI %   72.3% 115.0% 225.6% 197.3% 120.7% 78.9% 0.0% 0.0%   ROE %   59.2% 92.6% 173.8% 145.6% 92.5% 60.2% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   84.1% 35.5% 27.6% 27.1% 38.2% 69.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -124.0% -77.1% -66.0% -25.0% -75.2% -52.5% 0.0% 0.0%   Gearing %   1.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.4% 90.8% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   5.3 1.4 1.3 1.4 1.6 3.3 0.0 0.0   Current Ratio   5.3 1.4 1.3 1.4 1.6 3.3 0.0 0.0   Cash and cash equivalent   332.8 295.0 334.1 121.3 200.8 136.7 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   236.5 24.1 -10.0 185.6 165.5 443.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   133 383 253 243 158 130 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   133 383 253 243 133 130 0 0   EBIT / employee   112 344 239 218 133 130 0 0   Net earnings / employee   100 313 207 173 110 103 0 0